Edited sentence: (SIN:COPT) is an integrated pharmaceutical group in China.C & O Pharmaceutical Technology Holdings Ltd.The Company is engaged in research and development, to manufacturing, as well as marketing and distribution of C&O branded and third party pharmaceutical products across all parts of China.The company offers one-stop solutions to other pharmaceutical companies both in China and outside of China with its contract research organisation (CRO) and contract manufacturing organization (CMO) services, as well as product registration and distribution services.Three potential Category 1 drugs are also under development: an anti-Hepatitis B drug, new immuno-enhancer drug and alternative drug to cancer treatment, and Oxazolidinone antibiotics that is more effective against a broad spectrum of bacterial pathogens, especially Gram-positive drug-resistant bacteria.To expand its portfolio of proprietary drugs, the company is developing a range of drugs that address acute medical areas such as anti-infection, anti-HBV, anti-cancer, anti-tuberculosis, anti-aging and anti-obesity